We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Genentech Gets Form 483 for Postmarket Reporting Errors
Genentech Gets Form 483 for Postmarket Reporting Errors
January 8, 2013
Genentech failed to provide the FDA with timely adverse reaction reports associated with its various drugs, with many unreported cases languishing without an evaluation, according to a Form 483.